Table 6.
Antifungal and antibacterial activities of five major compounds.
| Antifungal strains | MIC80 (µg/mL) | ||||||
|---|---|---|---|---|---|---|---|
| Pinobanksin-3-acetate (28) | Pinocembrin (25) | Chrysin (32) | Galangin (34) | Prenyl caffeate (29) | Amphotericin B | ||
| Candida albicans | 250 | 62 | >250 | >250 | 62 | 0.125 | |
| Candida glabrata | 250 | 125 | >250 | >250 | 16 | 0.125 | |
| Aspergillus fumigatus | >250 | 250 | >250 | >250 | 125 | 6 | |
|
| |||||||
| Number | Bacterial strains | MIC100 (µg/mL) | |||||
| Pinobanksin-3-acetate (28) | Pinocembrin (25) | Chrysin (32) | Galangin (34) | Prenyl caffeate (29) | Oxacillin | ||
|
| |||||||
| 22 | Staphylococcus aureus (ATCC25923) | >100 | 100 ± 0 | >100 | >100 | 63 ± 6 | ≤0.25 |
| 23 | MRSA (0706C0025) | >100 | >100 | >100 | >100 | 70 ± 0 | ≥4 |
| 24 | MRSA (0702E0196) | >100 | >100 | >100 | >100 | 70 ± 0 | ≥4 |
| 25 | MSSA (0703H0036) | >100 | >100 | >100 | >100 | 93 ± 6 | ≤0.25 |
| 26 | MSSA (0701A0095) | >100 | >100 | >100 | >100 | 93 ± 6 | ≤0.25 |